Your browser doesn't support javascript.
loading
Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.
Vadhan-Raj, Saroj; Ford, David C; Dahl, Naomi V; Bernard, Kristine; Li, Zhu; Allen, Lee F; Strauss, William E.
Afiliação
  • Vadhan-Raj S; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ford DC; Toronto Digestive Disease Associates, Inc, Vaughan, Ontario, Canada.
  • Dahl NV; AMAG Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Bernard K; AMAG Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Li Z; AMAG Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Allen LF; AMAG Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Strauss WE; AMAG Pharmaceuticals, Inc, Waltham, Massachusetts.
Am J Hematol ; 91(2): E3-5, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26572233
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Ferropriva / Óxido Ferroso-Férrico / Hematínicos Limite: Humans Idioma: En Ano de publicação: 2016
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Ferropriva / Óxido Ferroso-Férrico / Hematínicos Limite: Humans Idioma: En Ano de publicação: 2016